Insulin-like growth factor-1 (IGF-1) is a growth and survival factor for oligodendrocyte lineage cells and induces myelination. Its actions are modulated by IGF binding proteins (IGFBPs) that are present in the extracellular fluids or on the cell surface. Additionally, IGFBPs are also known to exert
Insulin-like growth factor-binding protein 6 inhibits survival and differentiation of rat oligodendrocyte precursor cells
✍ Scribed by Nicole M. Kühl; Dick Hoekstra; Hans De Vries; Jacques De Keyser
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 290 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0894-1491
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Insulin‐like growth factor 1 (IGF‐1) is a growth and survival factor for oligodendrocyte lineage cells and promotes myelination. We demonstrate that IGF‐binding protein 6 (IGFBP‐6) is expressed and localized to the Golgi complex in rat oligodendrocyte precursor (O2A) cells. IGFBP‐6 mRNA showed a developmentally regulated expression pattern, displaying a transient decrease during early development, and enhanced levels upon cell maturation. IGFBP‐6 mRNA expression could be reduced by addition of basic fibroblast growth factor and progesterone while estrogen increased IGFBP‐6 mRNA. IGF‐1, platelet‐derived growth factor, and insulin had no effect. When added exogenously, IGFBP‐6 reduced O2A cell survival in the absence of IGF‐1 and inhibited IGF‐1‐stimulated survival in a partially IGF‐1‐dependent and partially IGF‐1‐independent fashion. In addition, IGFBP‐6 reduced the IGF‐stimulated expression of two myelin proteins, CNPase and MAG. Taken together, the data show that IGFBP‐6 is a new negative effector of oligodendrocyte survival and differentiation. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood. Rhabdomyosarcoma cell lines overexpress insulin-like growth factor-II (IGF-II), an autocrine growth factor that is inhibited by insulin-like growth factor binding protein-6 (IGFBP-6). IGFBP-6 is associated with myoblast quiescence
differentiation is linked to growth of Caco-2 cells, with markers of functional differentiation increasing only after the cells stop proliferating (Pinto e t al., 1983). Given these limitations, Caco-2 cells appear to represent the most relevant in vitro model currently available for study of prolif
Insulin-like growth factors, IGF-I and IGF-II, are potent regulators of oligodendrocyte development. Most of the IGF present in vivo is bound to members of a family of six high-affinity IGF-binding proteins (IGFBPs), which can either potentiate or inhibit IGF action, depending on other conditions. A
Previously we have shown that transforming growth factor b (TGF b) 1, basic fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) BB inhibit the synthesis of insulin-like growth factor (IGF) II, but their effects on IGF binding protein (IGFBP)-6 in osteoblast cultures are not kno
## Abstract Glucocorticoids (GCs) modulate insulin‐like growth factor action in cartilage through mechanisms that are complex and insufficiently defined, especially in the context of cranio‐facial growth. Because the family of IGF‐binding proteins (IGFBP‐1 to ‐6) is important in the regulation of I